Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115369) titled 'A study to test whether BI 690517 in combination with empagliflozin helps people with heart failure' on Dec. 25, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
heart failure
Intervention:
BI 690517 and empagliflozin,:BI 690517 and empagliflozin
Recruitment Status: Recruiting
Phase: 3
Date of First Enrollment: 2025-08-05
Target Sample Size: BI 690517 and empagliflozin,:3000;Placebo and empagliflozin:3000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=244827
Disclaimer...